Upstream Bio, Stock Market Value
| UPB Stock | 7.62 0.43 5.34% |
| Symbol | Upstream |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.771 | Quarterly Revenue Growth (0.02) |
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Upstream Bio, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Upstream Bio,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Upstream Bio,.
| 12/22/2024 |
| 03/22/2025 |
If you would invest 0.00 in Upstream Bio, on December 22, 2024 and sell it all today you would earn a total of 0.00 from holding Upstream Bio, or generate 0.0% return on investment in Upstream Bio, over 90 days. Upstream Bio, is related to or competes with Ryanair Holdings, ServiceNow, Toro, Sapiens International, ON24, Mills Music, and Rackspace Technology. Upstream Bio, is entity of United States More
Upstream Bio, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Upstream Bio,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Upstream Bio, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 29.15 | |||
| Value At Risk | (10.79) | |||
| Potential Upside | 10.53 |
Upstream Bio, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Upstream Bio,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Upstream Bio,'s standard deviation. In reality, there are many statistical measures that can use Upstream Bio, historical prices to predict the future Upstream Bio,'s volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.17) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.86) |
Upstream Bio, Backtested Returns
Upstream Bio, owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.2, which indicates the firm had a -0.2 % return per unit of risk over the last 3 months. Upstream Bio, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Upstream Bio,'s Coefficient Of Variation of (509.83), risk adjusted performance of (0.17), and Variance of 41.34 to confirm the risk estimate we provide. The entity has a beta of 1.47, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Upstream Bio, will likely underperform. At this point, Upstream Bio, has a negative expected return of -1.21%. Please make sure to validate Upstream Bio,'s value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Upstream Bio, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.49 |
Modest reverse predictability
Upstream Bio, has modest reverse predictability. Overlapping area represents the amount of predictability between Upstream Bio, time series from 22nd of December 2024 to 5th of February 2025 and 5th of February 2025 to 22nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Upstream Bio, price movement. The serial correlation of -0.49 indicates that about 49.0% of current Upstream Bio, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.5 |
Upstream Bio, lagged returns against current returns
Autocorrelation, which is Upstream Bio, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Upstream Bio,'s stock expected returns. We can calculate the autocorrelation of Upstream Bio, returns to help us make a trade decision. For example, suppose you find that Upstream Bio, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Upstream Bio, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Upstream Bio, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Upstream Bio, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Upstream Bio, stock over time.
Current vs Lagged Prices |
| Timeline |
Upstream Bio, Lagged Returns
When evaluating Upstream Bio,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Upstream Bio, stock have on its future price. Upstream Bio, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Upstream Bio, autocorrelation shows the relationship between Upstream Bio, stock current value and its past values and can show if there is a momentum factor associated with investing in Upstream Bio,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Upstream Bio, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Upstream Bio,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Upstream Bio, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Upstream Bio, Stock:Check out Upstream Bio, Correlation, Upstream Bio, Volatility and Upstream Bio, Alpha and Beta module to complement your research on Upstream Bio,. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Upstream Bio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.